Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
Nat Metab. 2022 Jun;4(6):759-774. doi: 10.1038/s42255-022-00585-x. Epub 2022 Jun 23.
Tissue macrophages (Mϕ) are essential effector cells in rheumatoid arthritis (RA), contributing to autoimmune tissue inflammation through diverse effector functions. Their arthritogenic potential depends on their proficiency to survive in the glucose-depleted environment of the inflamed joint. Here, we identify a mechanism that links metabolic adaptation to nutrient stress with the efficacy of tissue Mϕ to activate adaptive immunity by presenting antigen to tissue-invading T cells. Specifically, Mϕ populating the rheumatoid joint produce and respond to the small cytokine CCL18, which protects against cell death induced by glucose withdrawal. Mechanistically, CCL18 induces the transcription factor RFX5 that selectively upregulates glutamate dehydrogenase 1 (GLUD1), thus enabling glutamate utilization to support energy production. In parallel, RFX5 enhances surface expression of HLA-DR molecules, promoting Mϕ-dependent expansion of antigen-specific T cells. These data place CCL18 at the top of a RFX5-GLUD1 survival pathway and couple adaptability to nutrient conditions in the tissue environment to antigen-presenting function in autoimmune tissue inflammation.
组织巨噬细胞(Mϕ)是类风湿关节炎(RA)中的重要效应细胞,通过多种效应功能促进自身免疫性组织炎症。它们的关节炎发生潜力取决于它们在炎症关节中葡萄糖缺乏环境中生存的能力。在这里,我们确定了一种将代谢适应与营养应激联系起来的机制,这种机制与组织 Mϕ 激活适应性免疫的功效有关,即通过向组织浸润的 T 细胞呈递抗原。具体而言,浸润类风湿关节的 Mϕ 产生并对小细胞因子 CCL18 做出反应,CCL18 可防止葡萄糖耗竭诱导的细胞死亡。从机制上讲,CCL18 诱导转录因子 RFX5,选择性地上调谷氨酸脱氢酶 1(GLUD1),从而使谷氨酸能够用于支持能量产生。同时,RFX5 增强了 HLA-DR 分子的表面表达,促进了 Mϕ 依赖性抗原特异性 T 细胞的扩增。这些数据将 CCL18 置于 RFX5-GLUD1 生存途径的顶端,并将对组织环境中营养条件的适应性与自身免疫性组织炎症中的抗原呈递功能联系起来。